הכנסות החברה IDEXX Laboratories (IDXX)

סמל תאגידי ולוגו של idexx.com (IDXX)

IDEXX Laboratories, Inc. (IDXX) generates stable revenue based on the regular sale of test reagents. The company's sales growth rate reflects asset dynamics, where the value 4.66 represents the current metric. Stability is ensured by its own plants and laboratories, while technological leadership is solidified through the implementation of AI platforms and new rapid blood analyzers.

IDEXX Laboratories (IDXX) - מכירות החברה מ-04.07.2022 עד 16.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור IDEXX Corp (IDXX)

- מחיר ותחזית קונצנזוס למחירים:
ניתוח מסכם של החברה:idexx.com - IDXX
מוצר מקורי של IDEXX Lab

To identify the sector's fundamental leaders, the analyst evaluates the stability of cash inflows. Calculating daily revenue allows for the verification of operating cash flow sustainability and eliminates the risk of overpaying for an asset. For IDEXX Laboratories, Inc. (IDXX), this metric confirms the monetization of the absolute trust veterinary clinics place in the accuracy of their systems. High customer loyalty ensures predictable revenue growth. Regularly tracking the company's sales helps detect hidden financial imbalances in a timely manner.